These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38430890)
41. A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry. Begum F; Srivastava AK; Tripathi PP; Ray U J Med Virol; 2023 May; 95(5):e28796. PubMed ID: 37218551 [TBL] [Abstract][Full Text] [Related]
42. Epitope-directed anti-SARS-CoV-2 scFv engineered against the key spike protein region could block membrane fusion. Jaiswal D; Kumar U; Gaur V; Salunke DM Protein Sci; 2023 Mar; 32(3):e4575. PubMed ID: 36691733 [TBL] [Abstract][Full Text] [Related]
44. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways. Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690 [TBL] [Abstract][Full Text] [Related]
45. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation. Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407 [TBL] [Abstract][Full Text] [Related]
47. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. Liu Y; Liu J; Johnson BA; Xia H; Ku Z; Schindewolf C; Widen SG; An Z; Weaver SC; Menachery VD; Xie X; Shi PY Cell Rep; 2022 May; 39(7):110829. PubMed ID: 35550680 [TBL] [Abstract][Full Text] [Related]
48. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil. Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G; Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783 [TBL] [Abstract][Full Text] [Related]
49. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Hasan A; Paray BA; Hussain A; Qadir FA; Attar F; Aziz FM; Sharifi M; Derakhshankhah H; Rasti B; Mehrabi M; Shahpasand K; Saboury AA; Falahati M J Biomol Struct Dyn; 2021 May; 39(8):3025-3033. PubMed ID: 32274964 [TBL] [Abstract][Full Text] [Related]
50. A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts. Lorenz P; Steinbeck F; Mai F; Reisinger EC; Müller-Hilke B Front Immunol; 2023; 14():1192395. PubMed ID: 37228598 [TBL] [Abstract][Full Text] [Related]
51. Synthesis, evaluation, and mechanism of 1-(4-(arylethylenylcarbonyl)phenyl)-4-carboxy-2-pyrrolidinones as potent reversible SARS-CoV-2 entry inhibitors. Palla SR; Li CW; Chao TL; Lo HV; Liu JJ; Pan MY; Chiu YT; Lin WC; Hu CW; Yang CM; Chen YY; Fang JT; Lin SW; Lin YT; Lin HC; Kuo CJ; Wang LH; Chang SY; Liang PH Antiviral Res; 2023 Nov; 219():105735. PubMed ID: 37858764 [TBL] [Abstract][Full Text] [Related]
52. Why All the Fury over Furin? Osman EEA; Rehemtulla A; Neamati N J Med Chem; 2022 Feb; 65(4):2747-2784. PubMed ID: 34340303 [TBL] [Abstract][Full Text] [Related]
53. Temperature impacts SARS-CoV-2 spike fusogenicity and evolution. Dufloo J; Sanjuán R mBio; 2024 Apr; 15(4):e0336023. PubMed ID: 38411986 [TBL] [Abstract][Full Text] [Related]
54. The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV. Örd M; Faustova I; Loog M Sci Rep; 2020 Oct; 10(1):16944. PubMed ID: 33037310 [TBL] [Abstract][Full Text] [Related]
55. Variation of Proteolytic Cleavage Sites towards the N-Terminal End of the S2 Subunit of the Novel SARS-CoV-2 Omicron Sublineage BA.2.12.1. Schilling NA; Kalbacher H; Burster T Molecules; 2022 Sep; 27(18):. PubMed ID: 36144551 [TBL] [Abstract][Full Text] [Related]
56. SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation. Yu S; Zheng X; Zhou B; Li J; Chen M; Deng R; Wong G; Lavillette D; Meng G Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34930824 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of furin-like enzymatic activities and SARS-CoV-2 infection by osthole and phenolic compounds with aryl side chains. Kiba Y; Tanikawa T; Hayashi T; Kamauchi H; Seki T; Suzuki R; Kitamura M Biomed Pharmacother; 2023 Dec; 169():115940. PubMed ID: 38007936 [TBL] [Abstract][Full Text] [Related]
58. An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein. Ho C; Nazarie WFWM; Lee PC Viruses; 2023 Sep; 15(9):. PubMed ID: 37766336 [TBL] [Abstract][Full Text] [Related]
59. Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence. Vankadari N J Phys Chem Lett; 2020 Aug; 11(16):6655-6663. PubMed ID: 32787225 [TBL] [Abstract][Full Text] [Related]
60. Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects. Nguyen HT; Zhang S; Wang Q; Anang S; Wang J; Ding H; Kappes JC; Sodroski J J Virol; 2021 Mar; 95(5):. PubMed ID: 33310888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]